Codes / ICD10CM / T38.5X5

T38.5X5 Adverse effect of other estrogens and progestogens

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of other estrogens and progestogens

Summary

This condition refers to harmful or unintended reactions resulting from the use of estrogens or progestogens not classified elsewhere. It includes clinical scenarios where these agents cause adverse effects, such as allergic reactions, organ toxicity, or endocrine disturbances, without indicating poisoning or underdosing.

Causes

The causes include adverse reactions to prescribed or non-prescribed use of estrogens or progestogens. These may arise from individual sensitivity, drug interactions, or incorrect administration, leading to unintended physiological effects.

Risk Factors

  • Use of estrogen or progestogen therapies for medical conditions
  • Polypharmacy involving hormonal agents
  • Individual sensitivity to hormonal substances
  • Renal or hepatic impairment affecting drug metabolism
  • Concurrent use of medications that alter hormone metabolism

Symptoms

Symptoms vary based on the specific agent and individual response but may include nausea, vomiting, allergic reactions (e.g., rash, anaphylaxis), thromboembolic events, or endocrine disturbances (e.g., abnormal menstrual patterns, mood changes).

Diagnosis

Diagnosis requires a thorough patient history, including medication use and exposure details. Clinical evaluation and laboratory tests may be used to assess organ function or identify specific adverse effects, such as liver or renal impairment.

Treatment Options

Treatment focuses on managing symptoms and discontinuing the offending agent. Supportive care, such as antiemetics or antihistamines, may be provided. In severe cases, hospitalization for monitoring or specialized interventions (e.g., anticoagulation for thromboembolic events) may be necessary.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and timely intervention. Most cases resolve with discontinuation of the agent and supportive care. Follow-up may involve monitoring for resolution of symptoms or long-term effects, such as endocrine dysfunction.

Complications

Complications can include severe allergic reactions, thromboembolic events, organ damage (e.g., hepatic or renal), or persistent endocrine disturbances. Delayed treatment may increase the risk of adverse outcomes.

Lifestyle & Prevention

Prevention involves careful medication management, including adherence to prescribed dosing and avoiding polypharmacy. Patients should be educated on recognizing early signs of adverse effects and when to seek medical attention.

When to Seek Professional Help

Seek professional help if symptoms such as severe allergic reactions, chest pain, shortness of breath, or signs of organ dysfunction (e.g., jaundice, reduced urine output) occur. Prompt evaluation is critical for managing serious adverse effects.

Tips for Medical Coders

This code is used for adverse effects of estrogens or progestogens not classified elsewhere. Documentation should specify the agent involved, the nature of the adverse effect, and any contributing factors (e.g., drug interactions). Ensure the code aligns with clinical findings and avoids use for poisoning or underdosing scenarios.

Book a walkthrough

T38.5X5 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.